Search Results - "Angastiniotis, Michael"

Refine Results
  1. 1

    Thalassemias: An Overview by Angastiniotis, Michael, Lobitz, Stephan

    “…Thalassemia syndromes are among the most serious and common genetic conditions. They are indigenous in a wide but specific geographical area. However, through…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Addressing Thalassaemia Management from Patients' Perspectives: An International Collaborative Assessment by Economidou, Eleftheria C, Angastiniotis, Michael, Avraam, Demetris, Soteriades, Elpidoforos S, Eleftheriou, Androulla

    Published in Medicina (Kaunas, Lithuania) (01-04-2024)
    “…: The effective management of chronic diseases, particularly hereditary and rare diseases and thalassaemia, is an important indicator of the quality of…”
    Get full text
    Journal Article
  4. 4

    Haemoglobinopathies in Europe: health & migration policy perspectives by Aguilar Martinez, Patricia, Angastiniotis, Michael, Eleftheriou, Androulla, Gulbis, Beatrice, Mañú Pereira, Maria Del Mar, Petrova-Benedict, Roumyana, Corrons, Joan-Lluis Vives

    Published in Orphanet journal of rare diseases (01-07-2014)
    “…Major haemoglobinopathies (MH), such as thalassaemia syndromes (Thal) and sickle cell disorders (SCD), are genetic defects associated with chronic anaemia and…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Patient Care: Unmet Needs Globally by Angastiniotis, Michael, Eleftheriou, Androulla

    Published in Thalassemia reports (18-04-2018)
    “…Literature demonstrates that long survival and a good quality of life are achieved where the patients’ needs for holistic care are recognised and the…”
    Get full text
    Journal Article
  7. 7

    TIF Standards for Haemoglobinopathy Reference Centres by Angastiniotis, Michael, Eleftheriou, Androulla, Naveed, Mohammed, Assaf, Ali Al, Polynikis, Andreas, Soteriades, Elpidoforos S., Farmakis, Dimitrios

    Published in Thalassemia reports (01-03-2023)
    “…Haemoglobin disorders are hereditary, lifelong and characterised by the need for multifaceted management. The question of quality in meeting standards of care…”
    Get full text
    Journal Article
  8. 8

    Beta thalassemia: Looking to the future, addressing unmet needs and challenges by Angastiniotis, Michael

    Published in Annals of the New York Academy of Sciences (01-02-2024)
    “…Thalassemia management has reached new milestones, with new therapies promising the dawning of a new era. However, conventional and new approaches require…”
    Get full text
    Journal Article
  9. 9
  10. 10

    TIF 2.0: The Thal e-Course and TIF Expert Patients’ Programme for Disease-Related Education and Self-Management Skills in Thalassaemia by Antoniadou, Victoria, Angastiniotis, Michael, Eleftheriou, Androulla

    Published in Thalassemia reports (18-04-2018)
    “…In response to the fundamental shift that has been taking place in the way chronic diseases are perceived and managed and the increasingly established role of…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    3rd Pan-European Conference on Haemoglobinopathies and Rare Anaemias, 24–26 October 2012, Limassol, Cyprus by Eleftheriou, Androulla, Angastiniotis, Michael, Loukopoulos, Demitrios, Kattamis, Christos, Meletis, John

    Published in Thalassemia reports (20-12-2012)
    “…This abstract book contains all abstracts presented to the 3rd Pan-European Conference on Haemoglobinopathies and Rare Anaemias, 24–26 October 2012, Limassol,…”
    Get full text
    Journal Article
  14. 14

    The changing epidemiology of the ageing thalassaemia populations: A position statement of the Thalassaemia International Federation by Farmakis, Dimitrios, Giakoumis, Anastasios, Angastiniotis, Michael, Eleftheriou, Androulla

    Published in European journal of haematology (01-07-2020)
    “…Therapeutic advances in β‐thalassaemia have gradually lead to a significant improvement in prognosis over the past few decades. As a result, patients living in…”
    Get full text
    Journal Article
  15. 15

    COVID‐19 and thalassaemia: A position statement of the Thalassaemia International Federation by Farmakis, Dimitrios, Giakoumis, Anastasios, Cannon, Lily, Angastiniotis, Michael, Eleftheriou, Androulla

    Published in European journal of haematology (01-10-2020)
    “…Objectives Many patients with haemoglobinopathies, including thalassaemia and sickle cell disease, are at increased risk of developing severe complications…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The Need for Translational Epidemiology in Beta Thalassemia Syndromes by Soteriades, Soteris, Angastiniotis, Michael, Farmakis, Dimitrios, Eleftheriou, Androulla, Maggio, Aurelio

    “…Epidemiology is the practical tool to provide information on which policy makers should base planning of services. Epidemiological data for thalassemia is…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The Need for Translational Epidemiology in Beta Thalassemia Syndromes: A Thalassemia International Federation Perspective by Soteriades, Soterios, Angastiniotis, Michael, Farmakis, Dimitrios, Eleftheriou, Androulla, Maggio, Aurelio

    “…Epidemiology is the practical tool to provide information on which policy makers should base planning of services. Epidemiological data for thalassemia is…”
    Get full text
    Journal Article
  20. 20

    Thalassaemia Registries: A Call for Action. A Position Statement from the Thalassaemia International Federation by Farmakis, Dimitrios, Angastiniotis, Michael, El Ghoul, Maria-Melina, Cannon, Lily, Eleftheriou, Androulla

    Published in Hemoglobin (04-07-2022)
    “…Disease registries can be extremely powerful evidence generating tools while providing a central meeting point for all implicated stakeholders, facilitating…”
    Get full text
    Journal Article